Results for knoglemarvsdepression translation from Danish to English

knoglemarvsdepression
bone marrow suppression

knoglemarvsdepression,
bone marrow depression,

agranulocytose, knoglemarvsdepression
agranulocytosis, bone marrow depression

knoglemarvsdepression, +febril
bone marrow depression, +febrile

knoglemarvsdepression hypokaliæmi, hyponatriæmi
hypokalaemia, hyponatremia

agranulocytose, knoglemarvsdepression, hæmolytisk anæmi, leukopeni
agranulocytosis, bone marrow depression, haemolytic anaemia, leucopenia

trombocytæmi, lymfopeni, knoglemarvsdepression, eosinofili, lymfadenopati
thrombocythaemia, lymphopenia, bone marrow depression, eosinophilia, lymphadenopathy

der er rapporter om knoglemarvsdepression og andre hæmatologiske bivirkninger.
blood and lymphatic system disorders bone marrow suppression and other hematologic adverse reactions have been reported.

meget sjælden: agranulocytose, alvorlige forløb med knoglemarvsdepression.
very rare: agranulocytosis, severe courses of bone marrow depression.

blod og lymfesystem der er rapporter om knoglemarvsdepression og andre hæmatologiske bivirkninger.
blood and lymphatic system disorders bone marrow suppression and other hematologic adverse reactions have been reported.

på grund af dets kortvarige virkning inducerer estriol ikke knoglemarvsdepression hos hunden..
because of its short acting action, oestriol does not induce bone marrow suppression in the dog.

de primære forventede komplikationer ved en overdosis vil være knoglemarvsdepression, perifer neurotoksicitet og mucositis.
the primary anticipated complications of overdose would consist of bone marrow suppression, peripheral neurotoxicity and mucositis.

symptomerne på overdosering forventes dog at omfatte kvalme, opkastning, diaré og svær knoglemarvsdepression.
however, possible symptoms of overdose are expected to include nausea, vomiting, diarrhoea and severe bone marrow depression.

aplastisk anæmi, knoglemarvsdepression, neutropeni/agranulocytose, hæmolytisk anæmi, leukopeni, trombocytopeni
adverse events (regardless of relationship to medicinal product) reported with the use of hydrochlorothiazide alone include:

de fleste af disse patienter havde præ-eksisterende hæmatologiske lidelser, der ofte forbindes med knoglemarvsdepression.
most of these patients had pre-existing haematological disorders that are frequently associated with bone marrow failure.

pancytopeni, knoglemarvsdepression, leukopeni, trombocytopeni, purpura, anæmi dissemineret intravaskulær koagulation, agranulocytose, lymfadenopati, eosinofili
disorderscommon uncommonpancytopenia, bone marrow depression, leukopenia, thrombocytopenia, purpura, anaemia disseminated intravascular coagulation, agranulocytosis, lymphadenopathy, eosinophilia

anæmi (inkl. aplastisk anæmi) , hæmolytisk anæmi, knoglemarvsdepression, leukopeni, neutropeni, agranulocytose, trombocytopeni
anaemia (including aplastic anaemia) , haemolytic anaemia, bone marrow depression, leukopenia, neutropenia, agranulocytosis, thrombocytopenia

sygdomme i blod -og lymfesystemet:aplastisk anæmi, knoglemarvsdepression, neutropeni/agranulocytose, hæmolytisk anæmi, leukopeni, trombocytopeni
blood and lymphatic system: aplastic anaemia, bone marrow depression, neutropenia/agranulocytosis, haemolytic anaemia, leucopenia, thrombocytopenia

almindelig: trombocytopeni erfaring efter markedsføring: leukopeni, neutropeni, pancytopeni (hvor der i nogle af tilfældene blev identificeret knoglemarvsdepression)
common: thrombocytopenia post-marketing experience: leukopenia, neutropenia, pancytopenia (with bone marrow suppression identified in some of the cases)

pancytopeni, knoglemarvsdepression, anafylaktisk shock, psykotiske reaktioner, migræne, lugteforstyrrelser, nedsat hørelse, vasculitis, pancreatitis, levernekrose, petekkier, seneruptur
pancytopenia, bone marrow depression, anaphylactic shock, psychotic reactions, migraine, olfactory nerve disorders, hearing impaired, vasculitis, pancreatitis, liver necrosis, petechiae, tendon rupture